Solicitation of Nominations for Membership To Serve on the National Advisory Council on Migrant Health, 27790-27791 [2019-12592]
Download as PDF
<![CDATA[
jbell on DSK3GLQ082PROD with NOTICES
27790
Federal Register / Vol. 84, No. 115 / Friday, June 14, 2019 / Notices
available at https://www.fda.gov/
AdvisoryCommittees/Calendar/
default.htm. Scroll down to the
appropriate advisory committee meeting
link.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Oral presentations
from the public will be scheduled
between approximately 1 p.m. and 2
p.m. Those individuals interested in
making formal oral presentations should
notify the contact person and submit a
brief statement of the general nature of
the evidence or arguments they wish to
present, the names and addresses of
proposed participants, and an
indication of the approximate time
requested to make their presentation on
or before July 2, 2019. Time allotted for
each presentation may be limited. If the
number of registrants requesting to
speak is greater than can be reasonably
accommodated during the scheduled
open public hearing session, FDA may
conduct a lottery to determine the
speakers for the scheduled open public
hearing session. The contact person will
notify interested persons regarding their
request to speak by July 3, 2019.
Persons attending FDA’s advisory
committee meetings are advised that
FDA is not responsible for providing
access to electrical outlets.
For press inquiries, please contact the
Office of Media Affairs at fdaoma@
fda.hhs.gov or 301–796–4540.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with disabilities.
If you require accommodations due to a
disability, please contact Yinghua Wang
(see FOR FURTHER INFORMATION CONTACT)
at least 7 days in advance of the
meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our website at
https://www.fda.gov/
AdvisoryCommittees/AboutAdvisory
Committees/ucm111462.htm for
procedures on public conduct during
advisory committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: June 10, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
SUPPLEMENTARY INFORMATION:
[FR Doc. 2019–12559 Filed 6–13–19; 8:45 am]
BILLING CODE 4164–01–P
VerDate Sep<11>2014
17:04 Jun 13, 2019
Jkt 247001
Health Resources and Services
Administration
Solicitation of Nominations for
Membership To Serve on the National
Advisory Council on Migrant Health
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Request for nominations.
AGENCY:
HRSA is seeking nominations
of qualified candidates to be considered
for appointment as members of the
National Advisory Council on Migrant
Health (NACMH/Council). The NACMH
consults with and makes
recommendations to the HHS Secretary
concerning the organization, operation,
selection, and funding of migrant health
centers (MHC) and other entities, under
grants and contracts under the Public
Health Service (PHS) Act. HRSA is
seeking nominations to fill up to five
positions on the NACMH with
individuals served by nominating health
centers.
DATES: HRSA will receive written
nominations for NACMH membership
on a continuous basis.
ADDRESSES: Nomination packages must
be submitted in hardcopy to the
Designated Federal Official (DFO),
NACMH, Strategic Initiatives and
Planning Division, Office of Policy and
Program Development, Bureau of
Primary Health Care, HRSA, 16N38B,
5600 Fishers Lane, Rockville, Maryland
20857.
FOR FURTHER INFORMATION CONTACT: All
requests for information regarding
NACMH nominations should be sent to
Esther Paul, DFO, NACMH, HRSA, in
one of three ways: (1) Send a request to
the following address: Esther Paul,
Strategic Initiatives and Planning
Division, Office of Policy and Program
Development, Bureau of Primary Health
Care, HRSA, 16N38B, 5600 Fishers
Lane, Rockville, Maryland 20857; (2)
call 301–594–4300; or (3) send an email
to epaul@hrsa.gov. A copy of the
NACMH charter and list of the current
membership are available on the
NACMH website at https://
bphc.hrsa.gov/qualityimprovement/
strategicpartnerships/nacmh/
index.html.
SUMMARY:
NACMH
was established and authorized under
section 217 of the PHS Act, as amended
(42 U.S.C. 218), to consult with and
make recommendations to the HHS
Secretary concerning the organization,
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
operation, selection, and funding of
MHCs, and other entities under grants
and contracts under section 330 of the
PHS Act (42 U.S.C. 254b). The NACMH
meets twice each calendar year, or at the
discretion of the DFO in consultation
with the NACMH Chair.
Authority: NACMH is authorized
under section 217 of the PHS Act, as
amended (42 U.S.C. 218), and
established by the Secretary. The
NACMH is governed by the Federal
Advisory Committee Act (5 U.S.C.
Appendix 2) (FACA), which sets forth
standards for the formation and use of
advisory committees.
Nominations: HRSA requests
nominations for voting members to
serve as Special Government Employees
(SGEs) on the NACMH. The
nominations are to fill five open
positions with MHC governing board
members who are served by the
nominating MHC and who are familiar
with the delivery of health care to
migratory and seasonal agricultural
workers. The Secretary appoints
NACMH members with the expertise
needed to fulfill the duties of the
Advisory Committee. The membership
requirements set forth in section 217 of
the PHS Act, as amended (42 U.S.C.
218), require that the Council consist of
15 members, at least 12 of whom shall
be members of the governing boards of
MHCs or other entities assisted under
section 330 of the PHS Act (42 U.S.C.
254b). Of such 12 members, at least 9
shall be chosen from among those
members served by such health centers
and familiar with the delivery of health
care to migratory and seasonal
agricultural workers. The remaining
three Council members shall be
individuals qualified by training and
experience in the medical sciences or in
the administration of health programs.
New members filling a vacancy that
occurred prior to the expiration of a
term may serve only for the remainder
of such term. Members may serve after
the expiration of their terms until their
successors have taken office, but no
longer than 120 days. Nominees must
reside in the United States, and
international travel cannot be funded.
Individuals selected for appointment
to NACMH will be invited to serve for
up to 4 years as SGEs. Members
appointed as SGEs receive a stipend and
reimbursement for per diem and travel
expenses incurred for attending
NACMH meetings, as authorized by 5
U.S.C. 5703 of the FACA for persons
employed intermittently in government
service.
A complete nomination package
should include the following
information for each nominee: (1) A
E:\FR\FM\14JNN1.SGM
14JNN1
Federal Register / Vol. 84, No. 115 / Friday, June 14, 2019 / Notices
NACMH nomination form; (2) three
letters of reference; (3) a statement of
prior service on the NACMH; and (4) a
biographical sketch of the nominee or a
copy of his/her curriculum vitae.
Nomination packages may be submitted
directly by the nominated individual or
by the person/organization
recommending the candidate.
HHS will endeavor to ensure NACMH
membership is fairly balanced,
representing points of view and
individuals of diverse geographic areas,
gender, and ethnic and minority groups,
as well as individuals with disabilities.
Appointments shall be made without
discrimination based on age, ethnicity,
gender, sexual orientation, or cultural,
religious, or socioeconomic status.
Individuals selected to be considered
for appointment will be required to
provide detailed information regarding
their financial holdings, consultancies,
and research grants or contracts.
Disclosure of this information is
required in order for HRSA ethics
officials to determine whether there are
conflicts between the SGE’s public
duties as a member of the NACMH and
their private interests, including an
appearance of a loss of impartiality as
defined by federal laws and regulations,
and to identify any required remedial
action needed to address the potential
conflict(s).
Maria G. Button,
Director, Division of the Executive Secretariat.
[FR Doc. 2019–12592 Filed 6–13–19; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
jbell on DSK3GLQ082PROD with NOTICES
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; System
VerDate Sep<11>2014
17:04 Jun 13, 2019
Jkt 247001
for the Spec. of Acute THC Imp. Using
(1220).
Date: June 20, 2019.
Time: 10:00 a.m. to 11:00 a.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Neuroscience Center Building (NSC), 6001
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Susan O. McGuire, Ph.D.,
Scientific Review Officer, Office of
Extramural Policy and Review, National
Institute on Drug Abuse, National Institutes
of Health, DHHS, 6001 Executive Blvd.,
Room 4245, Rockville, MD 20852, 301–827–
5817, mcguireso@mail.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Preparation and Distribution of Research
Drug Products (8952).
Date: June 25, 2019.
Time: 11:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Neuroscience Center Building (NSC), 6001
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Lyle Furr, Scientific
Review Officer, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 4227, MSC 9550, 6001
Executive Boulevard, Bethesda, MD 20892–
9550, (301) 827–5702, lf33c.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Clinical
Research Coordination Center (2249).
Date: July 16, 2019.
Time: 11:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Neuroscience Center Building (NSC), 6001
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Lyle Furr, Scientific
Review Officer, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 4227, MSC 9550, 6001
Executive Boulevard, Bethesda, MD 20892–
9550, (301) 827–5702, lf33c.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: June 10, 2019.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–12525 Filed 6–13–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Eye Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
27791
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Eye Institute
Special Emphasis Panel; NEI Translational
Research Program (TRP) to Develop Novel
Therapies and Devices for the Treatment of
Visual System Disorders.
Date: July 15, 2019.
Time: 8:30 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Brian Hoshaw, Ph.D.,
Scientific Review Officer, National Eye
Institute, National Institutes of Health,
Division of Extramural Research, 6700 B
Rockledge Dr., Ste 3400, Rockville, MD
20892, 301–451–2020, hoshawb@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.867, Vision Research,
National Institutes of Health, HHS)
Dated: June 10, 2019.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–12526 Filed 6–13–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
E:\FR\FM\14JNN1.SGM
14JNN1
]]>Agencies
[Federal Register Volume 84, Number 115 (Friday, June 14, 2019)]
[Notices]
[Pages 27790-27791]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-12592]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Solicitation of Nominations for Membership To Serve on the
National Advisory Council on Migrant Health
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Request for nominations.
-----------------------------------------------------------------------
SUMMARY: HRSA is seeking nominations of qualified candidates to be
considered for appointment as members of the National Advisory Council
on Migrant Health (NACMH/Council). The NACMH consults with and makes
recommendations to the HHS Secretary concerning the organization,
operation, selection, and funding of migrant health centers (MHC) and
other entities, under grants and contracts under the Public Health
Service (PHS) Act. HRSA is seeking nominations to fill up to five
positions on the NACMH with individuals served by nominating health
centers.
DATES: HRSA will receive written nominations for NACMH membership on a
continuous basis.
ADDRESSES: Nomination packages must be submitted in hardcopy to the
Designated Federal Official (DFO), NACMH, Strategic Initiatives and
Planning Division, Office of Policy and Program Development, Bureau of
Primary Health Care, HRSA, 16N38B, 5600 Fishers Lane, Rockville,
Maryland 20857.
FOR FURTHER INFORMATION CONTACT: All requests for information regarding
NACMH nominations should be sent to Esther Paul, DFO, NACMH, HRSA, in
one of three ways: (1) Send a request to the following address: Esther
Paul, Strategic Initiatives and Planning Division, Office of Policy and
Program Development, Bureau of Primary Health Care, HRSA, 16N38B, 5600
Fishers Lane, Rockville, Maryland 20857; (2) call 301-594-4300; or (3)
send an email to [email protected]. A copy of the NACMH charter and list
of the current membership are available on the NACMH website at https://bphc.hrsa.gov/qualityimprovement/strategicpartnerships/nacmh/.
SUPPLEMENTARY INFORMATION: NACMH was established and authorized under
section 217 of the PHS Act, as amended (42 U.S.C. 218), to consult with
and make recommendations to the HHS Secretary concerning the
organization, operation, selection, and funding of MHCs, and other
entities under grants and contracts under section 330 of the PHS Act
(42 U.S.C. 254b). The NACMH meets twice each calendar year, or at the
discretion of the DFO in consultation with the NACMH Chair.
Authority: NACMH is authorized under section 217 of the PHS Act, as
amended (42 U.S.C. 218), and established by the Secretary. The NACMH is
governed by the Federal Advisory Committee Act (5 U.S.C. Appendix 2)
(FACA), which sets forth standards for the formation and use of
advisory committees.
Nominations: HRSA requests nominations for voting members to serve
as Special Government Employees (SGEs) on the NACMH. The nominations
are to fill five open positions with MHC governing board members who
are served by the nominating MHC and who are familiar with the delivery
of health care to migratory and seasonal agricultural workers. The
Secretary appoints NACMH members with the expertise needed to fulfill
the duties of the Advisory Committee. The membership requirements set
forth in section 217 of the PHS Act, as amended (42 U.S.C. 218),
require that the Council consist of 15 members, at least 12 of whom
shall be members of the governing boards of MHCs or other entities
assisted under section 330 of the PHS Act (42 U.S.C. 254b). Of such 12
members, at least 9 shall be chosen from among those members served by
such health centers and familiar with the delivery of health care to
migratory and seasonal agricultural workers. The remaining three
Council members shall be individuals qualified by training and
experience in the medical sciences or in the administration of health
programs. New members filling a vacancy that occurred prior to the
expiration of a term may serve only for the remainder of such term.
Members may serve after the expiration of their terms until their
successors have taken office, but no longer than 120 days. Nominees
must reside in the United States, and international travel cannot be
funded.
Individuals selected for appointment to NACMH will be invited to
serve for up to 4 years as SGEs. Members appointed as SGEs receive a
stipend and reimbursement for per diem and travel expenses incurred for
attending NACMH meetings, as authorized by 5 U.S.C. 5703 of the FACA
for persons employed intermittently in government service.
A complete nomination package should include the following
information for each nominee: (1) A
[[Page 27791]]
NACMH nomination form; (2) three letters of reference; (3) a statement
of prior service on the NACMH; and (4) a biographical sketch of the
nominee or a copy of his/her curriculum vitae. Nomination packages may
be submitted directly by the nominated individual or by the person/
organization recommending the candidate.
HHS will endeavor to ensure NACMH membership is fairly balanced,
representing points of view and individuals of diverse geographic
areas, gender, and ethnic and minority groups, as well as individuals
with disabilities. Appointments shall be made without discrimination
based on age, ethnicity, gender, sexual orientation, or cultural,
religious, or socioeconomic status.
Individuals selected to be considered for appointment will be
required to provide detailed information regarding their financial
holdings, consultancies, and research grants or contracts. Disclosure
of this information is required in order for HRSA ethics officials to
determine whether there are conflicts between the SGE's public duties
as a member of the NACMH and their private interests, including an
appearance of a loss of impartiality as defined by federal laws and
regulations, and to identify any required remedial action needed to
address the potential conflict(s).
Maria G. Button,
Director, Division of the Executive Secretariat.
[FR Doc. 2019-12592 Filed 6-13-19; 8:45 am]
BILLING CODE 4165-15-P
